+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

Colon (or colorectal/bowel cancer) is diagnosed in over 1 million people annually, and accounts for over 0.5 million deaths each year. According to a recent article in the renowned Lancet medical journal, in Europe the 5-year survival for colorectal cancer is less than 60% so there is certainly considerable market potential for effective and accessible new pharmaceutical drugs. Reports in the Colon Cancer Section will help industry operators, and those considering entering this market, to answer the key questions such as what are the latest clinical trials, what are the R&D trends, what is the potential for personalized medicine, where are the opportunities in major markets such as China and the US, etc. Show Less Read more

Global Colorectal Cancer Partnering 2010 to 2017 - Product Thumbnail Image

Global Colorectal Cancer Partnering 2010 to 2017

  • Report
  • March 2017
  • 150 Pages
From
From
From
From
Methotrexate (CAS 59-05-2) Market Research Report 2017 - Product Thumbnail Image

Methotrexate (CAS 59-05-2) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
Global and Chinese Irinotecan hcl Industry - 2017 - Product Thumbnail Image

Global and Chinese Irinotecan hcl Industry - 2017

  • Report
  • March 2017
  • 150 Pages
From
From
Global and Chinese Capecitabine Industry - 2017 - Product Thumbnail Image

Global and Chinese Capecitabine Industry - 2017

  • Report
  • March 2017
  • 150 Pages
From
Global and Chinese Fluorouracil Industry - 2017 - Product Thumbnail Image

Global and Chinese Fluorouracil Industry - 2017

  • Report
  • March 2017
  • 150 Pages
From
From
Colon Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Colon Cancer Treatment Drugs Markets in China

  • Report
  • March 2017
  • 199 Pages
From
From
From
From
From
Loading Indicator
adroll